Kpp Advisory Services LLC Cyclacel Pharmaceuticals, Inc. Call Options Transaction History
Kpp Advisory Services LLC
- $417 Billion
- Q3 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
About Cyclacel Pharmaceuticals, Inc.
- Ticker CYCC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,539,200
- Market Cap $5.27M
- Description
- Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combin...